Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-13 08:30 am Purchase | 2021-09-02 | 13G | BriaCell Therapeutics Corp. BCTX | K.J. Harrison & Partners Inc | 63,991 6.230% | 63,991 (New Position) | Filing History |
| 2021-09-07 4:05 pm Unchanged | 2021-09-01 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 102,000 10.000% | 0 (Unchanged) | Filing History |
| 2021-08-17 4:04 pm Purchase | 2021-08-09 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 58,667 5.800% | 58,667 (New Position) | Filing History |
| 2021-08-09 06:01 am Purchase | 2021-08-06 | 13D | BriaCell Therapeutics Corp. BCTX | Hyperscale Data Inc. GPUS | 59,000 6.150% | 59,000 (New Position) | Filing History |
| 2021-08-04 09:43 am Purchase | 2021-08-03 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 102,000 10.000% | 53,667 (+111.03%) | Filing History |
| 2021-06-28 4:15 pm Purchase | 2021-06-21 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 48,333 5.010% | 48,333 (New Position) | Filing History |
| 2021-06-14 1:14 pm Purchase | 2021-06-03 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 40,000 5.000% | 40,000 (New Position) | Filing History |
| 2021-03-08 4:16 pm Purchase | 2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX | Altium Capital Management LLC | 33,333 8.900% | 33,333 (New Position) | Filing History |
| 2021-03-05 4:13 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 66,667 16.300% | 66,667 (New Position) | Filing History |
| 2021-03-03 07:43 am Purchase | 2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX | SABBY MANAGEMENT LLC | 37,000 11.000% | 37,000 (New Position) | Filing History |
| 2021-03-02 12:06 pm Purchase | 2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX | Empery Asset Management LP | 34,094 8.890% | 34,094 (New Position) | Filing History |
| 2021-02-26 5:02 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 37,507 9.900% | 37,507 (New Position) | Filing History |
| 2021-02-26 09:02 am Purchase | 2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX | BIGGER CAPITAL FUND L P | 149,000 9.800% | 149,000 (New Position) | Filing History |